MARIMED INC. (MRMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 60M 120M 180M FY12: 785 FY13: 904 FY14: 88.4K FY15: 1.3M FY16: 3.6M FY17: 6.1M FY18: 11.9M FY19: 45.6M FY20: 50.9M FY21: 121.5M FY22: 134M FY23: 148.6M FY24: 157.7M FY25: 159.8M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

-25M 0 25M 50M 75M FY12: -19.2K FY13: -25.4K FY14: -101.8K FY15: -296.6K FY16: 1.9M FY17: 3.9M FY18: 7.8M FY19: 18.7M FY20: 31.3M FY21: 66.3M FY22: 64M FY23: 65.9M FY24: 62.6M FY25: 57.9M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY12: -774.8K FY13: -558.1K FY14: -817.3K FY15: -1.7M FY16: 775.3K FY17: 127.7K FY18: -5.4M FY19: -41.5M FY20: 14.5M FY21: 26.9M FY22: 20.4M FY23: 14.4M FY24: 2.6M FY25: -2.8M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-90M -60M -30M 0 30M 60M 90M FY12: -809.5K FY13: -535.6K FY14: -7.4M FY15: -1.8M FY16: -198.9K FY17: -1.2M FY18: -13.6M FY19: -81.2M FY20: 2.1M FY21: 7.2M FY22: 13.5M FY23: -16M FY24: -12.5M FY25: -14.5M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 35M 70M 105M FY12: 19.9K FY13: 26.3K FY14: 190.2K FY15: 1.6M FY16: 1.4M FY17: 2.2M FY18: 4M FY19: 26.9M FY20: 19.6M FY21: 55.2M FY22: 70.1M FY23: 82.7M FY24: 95.1M FY25: 101.9M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-30M -15M 0 15M 30M 45M FY12: -127.5K FY13: -10.7K FY14: -455.2K FY15: -392.9K FY16: -197.9K FY17: 1.8M FY18: -2.9M FY19: -24.1M FY20: 3.4M FY21: 35.9M FY22: 7.3M FY23: 7.9M FY24: 6.8M FY25: 7.7M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY14: -457.9K FY16: -3.6M FY17: -19.2M FY18: -11.8M FY19: -33.8M FY20: -1.3M FY21: 18M FY22: -4.8M FY23: -12.2M FY24: -5.2M FY25: 6.5M FY14 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 150M 300M 450M FY12: 19.8M FY13: 30.3M FY14: 31.9M FY15: 32M FY16: 52M FY19: 208.7M FY20: 324.2M FY21: 372.4M FY22: 380.3M FY23: 363.4M FY24: 379.2M FY25: 390.1M FY13 FY15 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q1 '12: -5.65 Q2 '12: 2.48 Q2 '13: -0.04 Q2 '14: -0.02 Q3 '14: -0.13 Q4 '15: -0.04 Q1 '16: -0.03 Q2 '16: -0.02 Q3 '16: -0.02 Q4 '16: -0.00 Q1 '17: -0.00 Q2 '17: 0.01 Q3 '17: 0.01 Q4 '17: -0.01 Q1 '18: -0.02 Q2 '18: -0.03 Q3 '18: -0.04 Q4 '18: -0.07 Q1 '19: -0.06 Q2 '19: -0.04 Q3 '19: -0.05 Q4 '19: -0.39 Q1 '20: -0.40 Q2 '20: -0.42 Q3 '20: -0.39 Q4 '20: 0.01 Q1 '21: 0.03 Q2 '21: 0.05 Q3 '21: 0.06 Q4 '22: 0.04 Q1 '23: 0.03 Q2 '23: 0.03 Q3 '23: 0.01 Q4 '23: -0.03 Q1 '24: -0.03 Q2 '24: -0.03 Q3 '24: -0.02 Q4 '24: -0.02 Q1 '25: -0.03 Q2 '25: -0.03 Q3 '25: -0.04 Q4 '25: -0.03 Q1 '26: -0.03 Q2 '26: -0.04 Q2 '12 Q2 '16 Q4 '17 Q2 '19 Q4 '20 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.